|
Cerepro(R) Application For Marketing Authorisation Accepted By EMEA, Europe (Medical News Today)
Ark Therapeutics Group plc (AKT: LSE) ("Ark" or "the Company") is pleased to announce today that the Marketing Authorisation Application (MAA) for Cerepro®, Ark's novel gene-based therapy for operable malignant glioma (brain cancer) which was recently filed with the European Medicines Regulatory Agency (EMEA), has cleared the validation stage. Search Engine Marketing Agency, Formic Media, Launches (PRWeb via Yahoo! News)
Formic Media, Inc., a search engine marketing (SEM) agency specializing in servicing small and local businesses, formally launched this week. Although relatively new to the Portland market, the SEM agency is kicking off the New Year with seasoned employees, active clients and strategic business partners. EMEA accepts Ark's MAA for Cerepro for review (PharmaBiz)
Ark Therapeutics Group plc (Ark) announced that the Marketing Authorisation Application (MAA) for Cerepro, its novel gene-based therapy for operable malignant glioma (brain cancer), which was recently filed with the European Medicines Regulatory Agency (EMEA), has cleared the validation stage. Lodging Interactive Launches HuBBub Social Media Marketing Platform for Hotels (Hospitality Net)
Lodging Interactive, a leading interactive marketing agency servicing the hospitality industry, today announced the roll out of HuBBubâ„¢, its Travel 2.0 Marketing Services for Hotels. Through the HuBBub Social Media Platform hotels can leverage Travel 2.0 technologies to maximize their online reach through conversational marketing opportunities on major social media websites such as Facebook, ... MedImmune submits MAA to EMEA for intranasal vaccine to prevent flu (PharmaBiz)
MedImmune, the global biologics unit of AstraZeneca, has submitted a Marketing Authorisation Application (MAA) for its nasal spray live attenuated influenza vaccine (LAIV), which is now being reviewed by the European Medicines Agency (EMEA). The proposed indication in the MAA is for prevention of seasonal influenza. Cayuse, Inc., Supports Biomedical Research of the Future with a Grants.gov Solution (Centre Daily Times)
Cayuse, Inc., a provider of Web-based grant proposal solutions for research organizations, has announced that version 3.6 of Cayuse424 allows researchers to prepare and submit grant applications for the NIH K (Career) Awards via Grants.gov. This version of Cayuse424 extends Cayuse's mission of streamlining the research funding process to new and early-state scientific researchers. Synovate Becomes the First Agency to Have Local Installation of Confirmit in China (PRWeb via Yahoo! News)
Synovate China, the largest customised research agency in China, has selected Confirmit as one of its platforms to support its online research business within mainland China. Medis Technologies Announces Senior Management Appointments; New Team Reflects Focus on Sales and Marketing Execution (PR Newswire via Yahoo! Finance)
Medis Technologies Ltd. , a leading fuel cell technology specialist, today announced several appointments to its executive and operational management team, reflecting the Company's evolution from a research and development organization to a commercial entity. Kansas Beef Council names Fleishman-Hillard as agency of record (BizJournals)
The Kansas Beef Council has tapped Fleishman-Hillard Inc. as its agency of record. Cayuse, Inc., Supports Biomedical Research of the Future with a Grants.gov Solution (Business Wire via Yahoo! Finance)
PORTLAND, Ore.----Cayuse, Inc., a provider of Web-based grant proposal solutions for research organizations, has announced that version 3.6 of Cayuse424 allows researchers to prepare and submit grant applications for the NIH K Awards via Grants.gov.
|
